Pancreatic Cancer Research

Preprint2023

Advancing Drug Development with aiHumanoid Simulations: A Virtual Phase 1 Comparative Study of Standard Chemotherapy versus Standard Chemotherapy plus COTI-2 for Pancreatic Adenocarcinoma

Published
10 September 2023
Citations
3
Type
Preprint

These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

abstract license unknown

Background Traditional Phase 1 trials often provide important drug development insights, which can be limited by ethical issues, costs, and lengthy timelines. Advancements in AI based simulations offer a potential avenue for mitigating these challenges. … Excerpt only: this text is the publisher’s. Read it in full at the source.